News
HEALTHCARE | Staff Reporter, Singapore
view(s)

Thomson Medical Group sets up $500m multicurrency debt issuance programme

The net proceeds will finance its borrowings, expansions and capital expenditure.

Thomson Medical Group has established a $500m multicurrency debt issuance programme, a filing with the Singapore Exchange (SGX) revealed.

Under the programme, the firm may issue notes and perpetual securities denominated in Singapore dollars or any other currency as may be agreed between the relevant dealers under the programme and the issuer. Each series or tranche of notes may be issued in various amounts and tenors, and may bear interest at fixed, floating, variable or hybrid rates or may not bear interest.

Also read: Singapore's top healthcare stocks hit average returns of 3.8% YTD

Perpetual securities have no fixed maturities, may be issued by the firm in various amounts, may bear fixed or floating rates of distribution, and, if so provided in the applicable pricing supplement, may have distributions deferred at the option of the issuer.

The net proceeds from each issue of securities under the programme, after deducting issue expenses, will be used for general corporate purposes of Thomson Medical and its subsidiaries, including refinancing of borrowings, financing potential acquisitions, strategic expansions, general working capital, capital expenditure and other investments.

An application has been made to the Singapore Exchange Securities Trading (SGX-ST) for the listing and quotation of any securities which are agreed at the time of issue thereof to be so listed on the SGX-ST.

“Such permission will be granted when such securities have been admitted to the official list of the SGX-ST,” the firm disclosed in its filing on the SGX.

Do you know more about this story? Contact us anonymously through this link.

Click here to learn about advertising, content sponsorship, events & rountables, custom media solutions, whitepaper writing, sales leads or eDM opportunities with us.

To get a media kit and information on advertising or sponsoring click here.